Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Immunome, Inc. (IMNM) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-69.90M |
|
-- |
|
-- |
|
$72.86M |
|
$-72.86M |
|
$2.96M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-72.86M |
|
$-72.08M |
|
87.35M |
|
87.35M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$660.78M |
|
$14.64M |
|
$22.41M |
|
$683.19M |
|
$44.99M |
|
-- |
|
$3.85M |
|
$48.84M |
|
$634.34M |
|
$634.34M |
|
$634.34M |
|
113.13M |
|
| Cash Flow Statement Financials | |
$-190.92M |
|
$60.80M |
|
$640.36M |
|
$143.45M |
|
$653.69M |
|
$510.24M |
|
$25.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.69 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-200.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.02% |
|
-11.02% |
|
-10.23% |
|
-11.02% |
|
$5.61 |
|
$-2.30 |
|
$-2.19 |
|